SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $15,000 | -70.6% | 58,623 | -72.3% | 0.00% | – |
| Q1 2016 | $51,000 | +131.8% | 211,912 | +235.2% | 0.00% | – |
| Q4 2015 | $22,000 | -48.8% | 63,227 | +158.8% | 0.00% | – |
| Q3 2015 | $43,000 | -34.8% | 24,430 | -17.5% | 0.00% | – |
| Q2 2015 | $66,000 | +32.0% | 29,611 | +15.4% | 0.00% | – |
| Q1 2015 | $50,000 | -62.1% | 25,650 | -48.4% | 0.00% | -100.0% |
| Q4 2014 | $132,000 | +1.5% | 49,745 | +15.2% | 0.00% | 0.0% |
| Q3 2014 | $130,000 | -90.0% | 43,186 | -86.4% | 0.00% | -87.5% |
| Q2 2014 | $1,303,000 | +102.3% | 318,681 | +113.3% | 0.01% | +166.7% |
| Q1 2014 | $644,000 | +64.7% | 149,430 | +100.2% | 0.00% | +50.0% |
| Q4 2013 | $391,000 | -21.3% | 74,633 | -5.3% | 0.00% | 0.0% |
| Q3 2013 | $497,000 | -36.4% | 78,813 | -49.6% | 0.00% | -50.0% |
| Q2 2013 | $781,000 | – | 156,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
| Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
| QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
| NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
| Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
| MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
| Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
| Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |